The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...
World Cancer Day on February 4 aims to raise awareness and encourage preventive measures. Highlighting the significant role ...
The Mirror US on MSN3h
Toddler’s ear infections were a sign of something far worse—now she has only days to liveA British family is devastated after discovering the dark truth behind their daughter's earaches, learning that she only has ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Mushrooms, sometimes called the “elixir of life,” have a long history of beauty and culinary excellence as well as medical ...
Cancer is the leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, or about one in six deaths, ...
Radiologists are beginning to use AI-based computer vision models to help speed up the laborious process of parsing medical ...
St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.
The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths ...
Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback